← All indications
Keratoconjunctivitis Sicca
Drying and inflammation of the conjunctiva as a result of insufficient lacrimal secretion. When found in association with XEROSTOMIA and polyarthritis, it is called SJOGREN'S SYNDROME.
Drugs by status
Approved for this indication (2)
Phase 3 trials (8)
Phase 2 trials (7)
Other trials (5)
Organizations
Organization Involved with Phase 4 Indications (68)
- Shire
- Bausch & Lomb
- Merck
- Akorn, Inc.
- Alcon
- Allergan
- Bp Consulting, Inc
- Santen Inc.
- GlaxoSmithKline
- Laboratoires Thea
- Mallinckrodt
- Ocular Therapeutix, Inc.
- Ocusoft, Inc.
- ORA, Inc.
- Samil Pharmaceutical Co., Ltd.
- Sun Pharmaceuticals
- Taejoon Pharm Co., Ltd.
- Lifelong Vision Foundation
- Edward Holland, MD
- University of Pittsburgh
- Chang Gung University
- Chulalongkorn University
- Cornell University
- Harvard University
- Eye and Vision Technologies and Research Institute
- Hermann Eye Center
- Niğde State Hospital
- Ophthalmic Consultants of Long Island
- Schepens Eye Research Institute
- Southern California College of Optometry
- +38 more
Organization Involved with Phase 3 Indications (72)
- Inspire Pharmaceuticals
- Acucela Inc.
- Senju Pharmaceuticals
- Sirion Therapeutics
- ISTA Pharmaceuticals
- Aldeyra Therapeutics, Inc.
- Aurinia Pharmaceuticals Inc.
- BRIM Biotechnology Inc.
- C.T. Development America, Inc.
- Can-Fite BioPharma
- DH Bio Co., Ltd.
- Eyegate Pharmaceuticals, Inc.
- HanAll BioPharma Co., Ltd.
- Hanlim Pharm. Co., Ltd.
- Huons Co.,Ltd.
- Kissei Pharmaceuticals
- Kala Pharmaceuticals, Inc.
- Laboratorios Sophia S.A de C.V.
- Lantibio
- Mimetogen Pharmaceuticals USA, Inc.
- Mitotech, SA
- Ocular Technologies SARL
- OmegaD LLC
- Physician Recommended Nutriceuticals
- RegeneRx Biopharmaceuticals, Inc.
- Seikagaku Corporation
- Sponsor GmbH
- Topivert Pharma Ltd
- Chong Kun Dang Pharmaceutical
- Daewoong Pharmaceutical Co. LTD.
- +42 more
Organization Involved with Phase 2 Indications (63)
- R-Tech Ueno
- Abbott
- Kowa
- Genentech
- Pfizer
- Palatin Technologies
- Alacrity Biosciences, Inc.
- Aerie Pharmaceuticals
- AVX Pharma
- Croma-Pharma GmbH
- Dhp Korea Co., Ltd.
- Dong-A Pharmaceutical
- GL Pharm Tech Corporation
- Herantis Pharma Plc.
- InSite Vision
- Parion Sciences
- Rhodes Pharmaceuticals, L.P.
- Rigel Pharmaceuticals
- Samjin Pharmaceutical Co., Ltd.
- Resolvyx Pharmaceuticals, Inc
- Winston Laboratories
- Xigen SA
- Price Vision Group
- Ariel University
- Duke University
- Kresge Eye Institute
- Michigan Cornea Consultants, PC
- National University of Malaysia
- Oregon Health and Science University
- University of Michigan
- +33 more
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (37)
- Aromtech Ltd.
- Eyeon Therapeutics, Inc.
- Tissue Tech Inc.
- Trima, Israel Pharmaceutical Products
- Aston University
- Baylor University
- Chung Shan Medical University
- China Academy of Chinese Medical Sciences
- Mahidol University
- Ohio State University
- Panhandle Eye Group, LLP
- University of Seville
- University of South Carolina
- Chonbuk National University
- Wenzhou Medical University
- University of Turku
- Medical University of South Carolina
- University of Indonesia
- Hebrew University
- Pennsylvania State University
- Tianjin University
- Soonchunhyang University
- Stiltec Pty Ltd
- Government of Australia
- TearLab Corporation
- The Finnish Funding Agency for Technology and Innovation
- Chonnam National University
- Nordic Naturals
- GRAPE KING
- The American Society of Cataract and Refractive Surgery Foundation
- +7 more